Catasys Inc. (NASDAQ:CATS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Monday.

According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “

Shares of Catasys (CATS) traded up 0.22% during midday trading on Monday, hitting $4.61. The company’s stock had a trading volume of 26,531 shares. Catasys has a 1-year low of $3.56 and a 1-year high of $14.00. The company’s market cap is $73.18 million. The company has a 50-day moving average price of $4.43 and a 200 day moving average price of $6.56.

WARNING: “Catasys Inc. (CATS) Stock Rating Upgraded by Zacks Investment Research” was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/07/catasys-inc-cats-stock-rating-upgraded-by-zacks-investment-research.html.

A hedge fund recently bought a new stake in Catasys stock. Perkins Capital Management Inc. bought a new position in shares of Catasys Inc. (NASDAQ:CATS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 24,700 shares of the company’s stock, valued at approximately $113,000. Perkins Capital Management Inc. owned 0.16% of Catasys at the end of the most recent quarter. Institutional investors and hedge funds own 2.19% of the company’s stock.

About Catasys

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.